Back
DBV Technologies SA Vs. Akari Therapeutics PLC Industry Stock Comparison
Buy
57
DBVT
DBV Technologies SA
Last Price:
0.77
Seasonality Move:
15.94%
Sell
40
AKTX
Akari Therapeutics PLC
Last Price:
2.42
Seasonality Move:
-3.74%
Buy
57
DBV Technologies SA (DBVT)
is a Buy
Is DBV Technologies SA a Buy, Sell or Hold?
- The current DBV Technologies SA [DBVT] share price is $0.76. The Score for DBVT is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- DBVT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
Akari Therapeutics PLC (AKTX)
is a Sell
Is Akari Therapeutics PLC a Buy, Sell or Hold?
- The current Akari Therapeutics PLC [AKTX] share price is $2.43. The Score for AKTX is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- AKTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DBVT Stock Price Chart
What is DBV Technologies SA's stock price today?
-
The DBV Technologies SA share price today is $0.76
The current trend is relatively stagnant and DBVT is experiencing selling pressure, which indicates risk of future bearish movement.
AKTX Stock Price Chart
What is Akari Therapeutics PLC's stock price today?
-
The Akari Therapeutics PLC share price today is $2.43
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
DBVT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 50.75 | Buy |
| Chaikin Money Flow: | -39224 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.67 - 0.79) | Buy |
| Bollinger Bands (100): | (0.73 - 0.93) | Sell |
AKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.14 | Sell |
| Relative Strength Index (14 RSI): | 43.98 | Sell |
| Chaikin Money Flow: | 19777 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.29 - 2.89) | Sell |
| Bollinger Bands (100): | (2.71 - 3.71) | Sell |
DBVT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.79 | Sell |
| 20-day SMA: | 0.74 | Buy |
| 50-day SMA: | 0.75 | Buy |
| 200-day SMA: | 1.15 | Sell |
| 8-day EMA: | 0.77 | Sell |
| 20-day EMA: | 0.76 | Buy |
| 50-day EMA: | 0.78 | Sell |
| 200-day EMA: | 1.19 | Sell |
AKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.46 | Sell |
| 20-day SMA: | 2.49 | Sell |
| 50-day SMA: | 2.98 | Sell |
| 200-day SMA: | 2.57 | Sell |
| 8-day EMA: | 2.46 | Sell |
| 20-day EMA: | 2.55 | Sell |
| 50-day EMA: | 2.82 | Sell |
| 200-day EMA: | 3.04 | Sell |
DBV Technologies SA Earnings Growth & DBVT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.19 per share.
Akari Therapeutics PLC Earnings Growth & AKTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and a decrease next year of $0.00 per share.
DBV Technologies SA Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Akari Therapeutics PLC Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||